Literature DB >> 10087215

Construction and analysis of a modified Tn4001 conferring chloramphenicol resistance in Mycoplasma pneumoniae.

T W Hahn1, E A Mothershed, R H Waldo, D C Krause.   

Abstract

The Staphylococcus aureus transposon Tn4001 and derivatives thereof have been transformed successfully in several mycoplasma species. In order to expand the versatility of Tn4001 for other genetic manipulations and for use in mycoplasma species resistant to gentamicin (Gm), chloramphenicol acetyltransferase (Cat) from S. aureus was evaluated as a selectable marker. The cat gene was cloned in both orientations into a modified Tn4001 and transformed into Mycoplasma pneumoniae, conferring resistance to Cm and Gm. Replacement of the gene for GmR in Tn4001 with cat likewise conferred CmR when transformed into M. pneumoniae. The minimum inhibitory concentration to Cm in transformants with cat derivatives of Tn4001 was 300-500 microg/ml, and Cat enzyme activity was demonstrated by using a fluorescent substrate. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10087215     DOI: 10.1006/plas.1998.1387

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  17 in total

1.  Transcriptional analysis of the hmw gene cluster of Mycoplasma pneumoniae.

Authors:  R H Waldo; P L Popham; C E Romero-Arroyo; E A Mothershed; K K Lee; D C Krause
Journal:  J Bacteriol       Date:  1999-08       Impact factor: 3.490

2.  Diversity of Tn4001 transposition products: the flanking IS256 elements can form tandem dimers and IS circles.

Authors:  M Prudhomme; C Turlan; J-P Claverys; M Chandler
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

3.  Use of fluorescent-protein tagging to determine the subcellular localization of mycoplasma pneumoniae proteins encoded by the cytadherence regulatory locus.

Authors:  Tsuyoshi Kenri; Shintaro Seto; Atsuko Horino; Yuko Sasaki; Tsuguo Sasaki; Makoto Miyata
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

4.  P65 truncation impacts P30 dynamics during Mycoplasma pneumoniae gliding.

Authors:  Benjamin M Hasselbring; Edward S Sheppard; Duncan C Krause
Journal:  J Bacteriol       Date:  2012-04-27       Impact factor: 3.490

5.  Targeted chromosomal knockouts in Mycoplasma pneumoniae.

Authors:  Radha Krishnakumar; Nacyra Assad-Garcia; Gwynedd A Benders; Quang Phan; Michael G Montague; John I Glass
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

6.  Synthesis, stability, and function of cytadhesin P1 and accessory protein B/C complex of Mycoplasma pneumoniae.

Authors:  Robert H Waldo; Duncan C Krause
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

7.  Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium.

Authors:  Jarrat L Jordan; How-Yi Chang; Mitchell F Balish; Lynley S Holt; Stephanie R Bose; Benjamin M Hasselbring; Robert H Waldo; Thomas M Krunkosky; Duncan C Krause
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

8.  Proteins P24 and P41 function in the regulation of terminal-organelle development and gliding motility in Mycoplasma pneumoniae.

Authors:  Benjamin M Hasselbring; Duncan C Krause
Journal:  J Bacteriol       Date:  2007-08-10       Impact factor: 3.490

9.  Mycoplasma pneumoniae cytoskeletal protein HMW2 and the architecture of the terminal organelle.

Authors:  Stephanie R Bose; Mitchell F Balish; Duncan C Krause
Journal:  J Bacteriol       Date:  2009-08-28       Impact factor: 3.490

10.  Mycoplasma pneumoniae J-domain protein required for terminal organelle function.

Authors:  Jason M Cloward; Duncan C Krause
Journal:  Mol Microbiol       Date:  2009-01-29       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.